EcoDrugPlus


Trade Names	FERROUS FUMARATE LO LOESTRIN FE
Synonyms	Cpiron Erco-fer Ercoferro Feostat Ferrofume Ferrosi fumaras Ferrous fumarate Fersaday Fersamal Galfer Heferol Hemoton Ircon Iron (as ferrous fumarate) Iron (as fumarate) Iron fumarate Meterfer Orgasal Palafer Toleron Tolferain Tolifer
Status
Molecule Category	Free-form
ATC	B03AA02 B03AD02
UNII	R5L488RY0Q

Trade Names

FERROUS FUMARATE

LO LOESTRIN FE

Synonyms

Cpiron

Erco-fer

Ercoferro

Feostat

Ferrofume

Ferrosi fumaras

Ferrous fumarate

Fersaday

Fersamal

Galfer

Heferol

Hemoton

Ircon

Iron (as ferrous fumarate)

Iron (as fumarate)

Iron fumarate

Meterfer

Orgasal

Palafer

Toleron

Tolferain

Tolifer

Status

Molecule Category

Free-form

ATC

B03AA02 B03AD02

UNII

R5L488RY0Q


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Property Name	Value
Molecular Formula	C4H2FeO4
Molecular Weight	169.9
AlogP	None
Hydrogen Bond Acceptor	None
Hydrogen Bond Donor	None
Number of Rotational Bond	None
Polar Surface Area	None
Molecular species	None
Aromatic Rings	None
Heavy Atoms	None

Property Name

Value

Molecular Formula

C4H2FeO4

Molecular Weight

169.9

AlogP

None

Hydrogen Bond Acceptor

None

Hydrogen Bond Donor

None

Number of Rotational Bond

None

Polar Surface Area

None

Molecular species

None

Aromatic Rings

None

Heavy Atoms

None

Mechanism of Action	Action	Reference
Supplement	None	BNF DailyMed

Mechanism of Action

Action

Reference

Supplement

None

BNF DailyMed

Resources	Reference
ChEMBL	CHEMBL1200640
FDA SRS	R5L488RY0Q
PubChem	6433164

Resources

Reference

ChEMBL

CHEMBL1200640

FDA SRS

R5L488RY0Q

PubChem

6433164


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

FERROUS FUMARATE

Physicochemical Descriptors

Bioactivity

Cross References